IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lion Point Capital, LP

Q1 2025 Holdings

Filed 2025-05-15 | 21 holdings | $15.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Insmed Inc(INSM)COM PAR $.01457669307$2.3M30,50014.8%
Ardelyx Inc(ARDX)COM039697107$1.6M335,40010.5%
Mineralys Therapeutics Inc(MLYS)COM603170101$1.3M79,0008.0%
Fennec Pharmaceuticals Inc(FENC)COM31447P100$1.2M195,7007.6%
Kiniksa Pharmaceuticals LTD(KNSA)ORD SHS CL AG52694109$1.0M45,9006.5%
Bridgebio Pharma Inc(BBIO)COM10806X102$898.8K26,0005.7%
Benitec Biopharma Inc(BNTC)COM NEW08205P209$806.6K62,0005.1%
Geron Corp(GERN)COM374163103$795.0K500,0005.1%
Avadel Pharmaceuticals PLCCOM SHSG29687103$772.8K98,7004.9%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$724.1K46,3004.6%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$675.7K55,0004.3%
Jasper Therapeutics Inc(JSPR)COM NEW471871202$630.0K146,5004.0%
Biohaven LTD(BHVN)COMG1110E107$545.7K22,7003.5%
Disc Medicine Inc(IRON)COM254604101$526.2K10,6003.4%
Milestone Pharmaceuticals in(MIST)COM59935V107$439.1K548,8062.8%
Regenxbio Inc(RGNX)COM75901B107$412.9K57,7502.6%
Bluebird BIO Inc(BLE0)COM NEW09609G209$385.1K78,9122.5%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$238.5K340,7611.5%
Mersana Therapeutics IncCOM59045L106$221.7K644,0001.4%
Humacyte Inc(HUMA)COM44486Q103$142.4K83,5000.9%
Spruce Biosciences IncCOM85209E109$21.8K75,0000.1%